Washington, D.C. Briefing to Address FDA's Denial of Access to Experimental Treatments for the Terminally Ill

In an effort to end FDA actions that block access of terminally ill patients to experimental drugs, the producers of the groundbreaking film Cut Poison Burn together with advocates of a new Medical Freedom of Choice bill will present a screening of the film and will introduce the new bill to Congress.


New York, July 18, 2012 (GLOBE NEWSWIRE) -- Presented by producers Louis Cimino and Wayne Chesler and Academy-award winning executives from NEHST Studios, the documentary 'Cut Poison Burn' will be presented at a private screening on July 25th, 2012 at the Rayburn Gold Room in Capitol Hill. The screening will be followed by a panel discussion featuring Oncology, government and regulatory thought-leaders.

With the tagline 'when the war on Cancer becomes a war against cancer patients' and featuring real patient stories, industry and FDA insiders and world-renowned medical professionals, the documentary delivers a compelling critique of the U.S. healthcare system and heart wrenching examples of FDA refusals to permit access to medically recommended experimental treatments by the terminally ill.  

Special guests and a panel of experts will include: Diane Ladd - Academy Award winning actor and healthcare advocate; Jonathan W. Emord - Attorney and Legal Columnist, U.S.A. Today Magazine; Charles B. Simone - Masters of Medical Science, Medical Doctor, Medical Oncologist, Immunologist, and Radiation Oncologist, and Donna Navarro, whose son's story is featured in the film and others.

'Cut Poison Burn' has sparked a growing following of patients, professionals, advocacy groups and former big-pharma executives concerned about the roadblocks imposed on medical innovation for the treatment of chronic diseases like cancer. In addition, the film's compilation of data, testimonials and evidence has resulted in the development of the 'Medical Freedom of Choice Bill' to be introduced shortly by Congressman Ron Paul.

Dr. Paul intends to sponsor the Freedom of Choice Bill in Congress to enable terminally ill patients whose physicians have determined that FDA approved treatments are not curative to access experimental drugs upon execution of an informed consent, without need for FDA prior approval.

Those who endorse this bill include the Alliance for Natural Health-USA (www.anh-usa.org); the Abigail Alliance (abigail-alliance.org); additional patient groups representing the terminally ill; and individual terminally ill patients who have been denied access to experimental drugs. In addition private entities like XL Alliance (xlalliance.com) are also providing support to drive increased awareness of the film and its related causes.

For more information about the film and to learn how to get involved visit: www.cutpoisonburn.com. The event will take place on Wednesday, July 25th, 2012 - from 1PM to 3PM in the Rayburn Gold Room in Washington, D.C. To RSVP and for media credentials please email info@nehst.com

About Nehst

Nehst Media Enterprises is a content financing, development, production and distribution company innovating in many facets of the entertainment world. Nehst is founded on the premise that today's media landscape requires content development and distribution focused on niche marketing, community and branding. Nehst applies unique strategies to information technology to discover, produce and distribute content people care about. More information about Nehst is available at www.nehst.com

About the Film:

CUT POISON BURN is a searing film that illuminates a concerning truth about America's 'War on Cancer.' This thought-provoking documentary featuring testimonials from industry and FDA insiders, medical experts and patients, uncovers systems and entities that have impaired meaningful advances in cancer research, trial, treatment and outcomes over the past century. The story centers on the Navarro's, a family struggling to keep their young son Thomas alive. As the personal meets the political, we see how the FDA limits innovation, treatment options and patients' freedom of choice. Heart wrenching and informative, the film ultimately expresses hope that we can create a new paradigm of prevention, medical freedom and acceptance of highly tailored therapies to usher in a more enlightened, data-driven and global era. For more information visit: www.cutpoisonburn.com.


            

Contact Data